Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma
Clinical trial NCT01216826 · UNKNOWN
Trial details
- NCT number
- NCT01216826
- Sponsor
- Sidnei Epelman
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.